{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,8]],"date-time":"2026-01-08T06:43:16Z","timestamp":1767854596828,"version":"3.49.0"},"reference-count":42,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2010,7,27]],"date-time":"2010-07-27T00:00:00Z","timestamp":1280188800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Comput Aided Mol Des"],"published-print":{"date-parts":[[2010,10]]},"DOI":"10.1007\/s10822-010-9375-z","type":"journal-article","created":{"date-parts":[[2010,7,26]],"date-time":"2010-07-26T09:36:30Z","timestamp":1280136990000},"page":"803-817","source":"Crossref","is-referenced-by-count":11,"title":["Fragment-guided approach to incorporating structural information into a CoMFA study: BACE-1 as an example"],"prefix":"10.1007","volume":"24","author":[{"given":"L\u00edvia Barros","family":"Salum","sequence":"first","affiliation":[]},{"given":"Napole\u00e3o Fonseca","family":"Valadares","sequence":"additional","affiliation":[]}],"member":"297","published-online":{"date-parts":[[2010,7,27]]},"reference":[{"key":"9375_CR1","doi-asserted-by":"crossref","first-page":"780","DOI":"10.1038\/nm0706-780","volume":"12","author":"C Mount","year":"2006","unstructured":"Mount C, Downton C (2006) Alzheimer disease: progress or profit? Nat Med 12:780\u2013784","journal-title":"Nat Med"},{"key":"9375_CR2","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1001\/archneur.60.8.1119","volume":"60","author":"LE Hebert","year":"2003","unstructured":"Hebert LE, Scherr PA, Bienias JL, Bennett DA, Evans DA (2003) Alzheimer disease in the US population: prevalence estimates using the 2000 census. Arch Neurol 60:1119\u20131122","journal-title":"Arch Neurol"},{"key":"9375_CR3","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.2105\/AJPH.84.8.1261","volume":"84","author":"RL Ernst","year":"1994","unstructured":"Ernst RL, Hay JW (1994) The US economic and social costs of Alzheimer\u2019s disease revisited. Am J Public Health 84:1261\u20131264","journal-title":"Am J Public Health"},{"key":"9375_CR4","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1002\/ddr.20289","volume":"70","author":"SJ Stachel","year":"2009","unstructured":"Stachel SJ (2009) Progress toward the development of a viable BACE-1 inhibitor. Drug Dev Res 70:101\u2013110","journal-title":"Drug Dev Res"},{"key":"9375_CR5","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1038\/nrd2314","volume":"6","author":"I Melnikova","year":"2007","unstructured":"Melnikova I (2007) Therapies for Alzheimer\u2019s disease. Nat Rev Drug Discov 6:341\u2013342","journal-title":"Nat Rev Drug Discov"},{"key":"9375_CR6","doi-asserted-by":"crossref","first-page":"1589","DOI":"10.1016\/S0169-409X(02)00157-6","volume":"54","author":"R Vassar","year":"2002","unstructured":"Vassar R (2002) Beta-secretase (BACE) as a drug target for Alzheimer\u2019s disease. Adv Drug Deliv Rev 54:1589\u20131602","journal-title":"Adv Drug Deliv Rev"},{"key":"9375_CR7","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1038\/nrm2101","volume":"8","author":"C Haass","year":"2007","unstructured":"Haass C, Selkoe DJ (2007) Soluble protein oligomers in neurodegeneration: lessons from the Alzheimer\u2019s amyloid beta-peptide. Nat Rev Mol Cell Biol 8:101\u2013112","journal-title":"Nat Rev Mol Cell Biol"},{"key":"9375_CR8","doi-asserted-by":"crossref","first-page":"1845","DOI":"10.1111\/j.1742-4658.2009.06929.x","volume":"276","author":"CE Hunt","year":"2009","unstructured":"Hunt CE, Turner AJ (2009) Cell biology, regulation and inhibition of beta-secretase (BACE-1). FEBS J 276:1845\u20131859","journal-title":"FEBS J"},{"key":"9375_CR9","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1126\/science.1566067","volume":"256","author":"JA Hardy","year":"1992","unstructured":"Hardy JA, Higgins GA (1992) Alzheimer\u2019s disease: the amyloid cascade hypothesis. Science 256:184\u2013185","journal-title":"Science"},{"key":"9375_CR10","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1126\/science.1072994","volume":"297","author":"J Hardy","year":"2002","unstructured":"Hardy J, Selkoe DJ (2002) The amyloid hypothesis of Alzheimer\u2019s disease: progress and problems on the road to therapeutics. Science 297:353\u2013356","journal-title":"Science"},{"key":"9375_CR11","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.1111\/j.1471-4159.2009.06181.x","volume":"110","author":"J Hardy","year":"2009","unstructured":"Hardy J (2009) The amyloid hypothesis for Alzheimer\u2019s disease: a critical reappraisal. J Neurochem 110:1129\u20131134","journal-title":"J Neurochem"},{"key":"9375_CR12","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1038\/85059","volume":"4","author":"Y Luo","year":"2001","unstructured":"Luo Y, Bolon B, Kahn S, Bennett BD, Babu-Khan S, Denis P, Fan W, Kha H, Zhang J, Gong Y, Martin L, Louis JC, Yan Q, Richards WG, Citron M, Vassar R (2001) Mice deficient in BACE1, the Alzheimer\u2019s beta-secretase, have normal phenotype and abolished beta-amyloid generation. Nat Neurosci 4:231\u2013232","journal-title":"Nat Neurosci"},{"key":"9375_CR13","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.1093\/hmg\/10.12.1317","volume":"10","author":"SL Roberds","year":"2001","unstructured":"Roberds SL, Anderson J, Basi G, Bienkowski MJ, Branstetter DG, Chen KS, Freedman SB, Frigon NL, Games D, Hu K, Johnson-Wood K, Kappenman KE, Kawabe TT, Kola I, Kuehn R, Lee M, Liu W, Motter R, Nichols NF, Power M, Robertson DW, Schenk D, Schoor M, Shopp GM, Shuck ME, Sinha S, Svensson KA, Tatsuno G, Tintrup H, Wijsman J, Wright S, McConlogue L (2001) BACE knockout mice are healthy despite lacking the primary beta-secretase activity in brain: implications for Alzheimer\u2019s disease therapeutics. Hum Mol Genet 10:1317\u20131324","journal-title":"Hum Mol Genet"},{"key":"9375_CR14","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1002\/med.20132","volume":"29","author":"R Silvestri","year":"2009","unstructured":"Silvestri R (2009) Boom in the development of non-peptidic beta-secretase (BACE1) inhibitors for the treatment of Alzheimer\u2019s disease. Med Res Rev 29:295\u2013338","journal-title":"Med Res Rev"},{"key":"9375_CR15","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1126\/science.290.5489.150","volume":"290","author":"L Hong","year":"2000","unstructured":"Hong L, Koelsch G, Lin X, Wu S, Terzyan S, Ghosh AK, Zhang XC, Tang J (2000) Structure of the protease domain of memapsin 2 (beta-secretase) complexed with inhibitor. Science 290:150\u2013153","journal-title":"Science"},{"key":"9375_CR16","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1016\/j.bmcl.2007.12.017","volume":"18","author":"B Clarke","year":"2008","unstructured":"Clarke B, Demont E, Dingwall C, Dunsdon R, Faller A, Hawkins J, Hussain I, MacPherson D, Maile G, Matico R, Milner P, Mosley J, Naylor A, O\u2019Brien A, Redshaw S, Riddell D, Rowland P, Soleil V, Smith KJ, Stanway S, Stemp G, Sweitzer S, Theobald P, Vesey D, Walter DS, Ward J, Wayne G (2008) BACE-1 inhibitors part 1: identification of novel hydroxy ethylamines (HEAs). Bioorg Med Chem Lett 18:1011\u20131016","journal-title":"Bioorg Med Chem Lett"},{"key":"9375_CR17","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1016\/j.bmcl.2007.12.019","volume":"18","author":"B Clarke","year":"2008","unstructured":"Clarke B, Demont E, Dingwall C, Dunsdon R, Faller A, Hawkins J, Hussain I, MacPherson D, Maile G, Matico R, Milner P, Mosley J, Naylor A, O\u2019Brien A, Redshaw S, Riddell D, Rowland P, Soleil V, Smith KJ, Stanway S, Stemp G, Sweitzer S, Theobald P, Vesey D, Walter DS, Ward J, Wayne G (2008) BACE-1 inhibitors part 2: identification of hydroxy ethylamines (HEAs) with reduced peptidic character. Bioorg Med Chem Lett 18:1017\u20131021","journal-title":"Bioorg Med Chem Lett"},{"key":"9375_CR18","doi-asserted-by":"crossref","first-page":"1022","DOI":"10.1016\/j.bmcl.2007.12.020","volume":"18","author":"P Beswick","year":"2008","unstructured":"Beswick P, Charrier N, Clarke B, Demont E, Dingwall C, Dunsdon R, Faller A, Gleave R, Hawkins J, Hussain I, Johnson CN, MacPherson D, Maile G, Matico R, Milner P, Mosley J, Naylor A, O\u2019Brien A, Redshaw S, Riddell D, Rowland P, Skidmore J, Soleil V, Smith KJ, Stanway S, Stemp G, Stuart A, Sweitzer S, Theobald P, Vesey D, Walter DS, Ward J, Wayne G (2008) BACE-1 inhibitors part 3: identification of hydroxy ethylamines (HEAs) with nanomolar potency in cells. Bioorg Med Chem Lett 18:1022\u20131026","journal-title":"Bioorg Med Chem Lett"},{"key":"9375_CR19","doi-asserted-by":"crossref","first-page":"3313","DOI":"10.1021\/jm800138h","volume":"51","author":"N Charrier","year":"2008","unstructured":"Charrier N, Clarke B, Cutler L, Demont E, Dingwall C, Dunsdon R, East P, Hawkins J, Howes C, Hussain I, Jeffrey P, Maile G, Matico R, Mosley J, Naylor A, O\u2019Brien A, Redshaw S, Rowland P, Soleil V, Smith KJ, Sweitzer S, Theobald P, Vesey D, Walter DS, Wayne G (2008) Second generation of hydroxyethylamine BACE-1 inhibitors: optimizing potency and oral bioavailability. J Med Chem 51:3313\u20133317","journal-title":"J Med Chem"},{"key":"9375_CR20","doi-asserted-by":"crossref","first-page":"3664","DOI":"10.1016\/j.bmcl.2009.03.165","volume":"19","author":"N Charrier","year":"2009","unstructured":"Charrier N, Clarke B, Cutler L, Demont E, Dingwall C, Dunsdon R, Hawkins J, Howes C, Hubbard J, Hussain I, Maile G, Matico R, Mosley J, Naylor A, O\u2019Brien A, Redshaw S, Rowland P, Soleil V, Smith KJ, Sweitzer S, Theobald P, Vesey D, Walter DS, Wayne G (2009) Second generation of BACE-1 inhibitors. Part 1: the need for improved pharmacokinetics. Bioorg Med Chem Lett 19:3664\u20133668","journal-title":"Bioorg Med Chem Lett"},{"key":"9375_CR21","doi-asserted-by":"crossref","first-page":"3669","DOI":"10.1016\/j.bmcl.2009.03.150","volume":"19","author":"N Charrier","year":"2009","unstructured":"Charrier N, Clarke B, Demont E, Dingwall C, Dunsdon R, Hawkins J, Hubbard J, Hussain I, Maile G, Matico R, Mosley J, Naylor A, O\u2019Brien A, Redshaw S, Rowland P, Soleil V, Smith KJ, Sweitzer S, Theobald P, Vesey D, Walter DS, Wayne G (2009) Second generation of BACE-1 inhibitors part 2: optimisation of the non-prime side substituent. Bioorg Med Chem Lett 19:3669\u20133673","journal-title":"Bioorg Med Chem Lett"},{"key":"9375_CR22","doi-asserted-by":"crossref","first-page":"3674","DOI":"10.1016\/j.bmcl.2009.03.149","volume":"19","author":"N Charrier","year":"2009","unstructured":"Charrier N, Clarke B, Cutler L, Demont E, Dingwall C, Dunsdon R, Hawkins J, Howes C, Hubbard J, Hussain I, Maile G, Matico R, Mosley J, Naylor A, O\u2019Brien A, Redshaw S, Rowland P, Soleil V, Smith KJ, Sweitzer S, Theobald P, Vesey D, Walter DS, Wayne G (2009) Second generation of BACE-1 inhibitors part 3: towards non hydroxyethylamine transition state mimetics. Bioorg Med Chem Lett 19:3674\u20133678","journal-title":"Bioorg Med Chem Lett"},{"key":"9375_CR23","doi-asserted-by":"crossref","first-page":"5959","DOI":"10.1021\/ja00226a005","volume":"110","author":"RD Cramer","year":"1988","unstructured":"Cramer RD, Patterson DE, Bunce JD (1988) Comparative molecular field analysis (Comfa) 0.1. Effect of shape on binding of steroids to carrier proteins. J Am Chem Soc 110:5959\u20135967","journal-title":"J Am Chem Soc"},{"key":"9375_CR24","unstructured":"The PyMOL molecular graphics system, version 1.2r3pre, Schr\u00f6dinger, LLC"},{"key":"9375_CR25","doi-asserted-by":"crossref","first-page":"4609","DOI":"10.1016\/j.bmc.2007.04.015","volume":"15","author":"NF Valadares","year":"2007","unstructured":"Valadares NF, Castilho MS, Polikarpov I, Garratt RC (2007) 2D QSAR studies on thyroid hormone receptor ligands. Bioorg Med Chem 15:4609\u20134617","journal-title":"Bioorg Med Chem"},{"key":"9375_CR26","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1517\/17460441003782277","volume":"5","author":"LB Salum","year":"2010","unstructured":"Salum LB, Andricopulo AD (2010) Fragment-based QSAR strategies in drug design. Expert Opin Drug Discov 5:405\u2013412","journal-title":"Expert Opin Drug Discov"},{"key":"9375_CR27","doi-asserted-by":"crossref","first-page":"3494","DOI":"10.2174\/138161207782794257","volume":"13","author":"A Tropsha","year":"2007","unstructured":"Tropsha A, Golbraikh A (2007) Predictive QSAR modeling workflow, model applicability domains, and virtual screening. Curr Pharm Des 13:3494\u20133504","journal-title":"Curr Pharm Des"},{"key":"9375_CR28","doi-asserted-by":"crossref","first-page":"4130","DOI":"10.1021\/jm00050a010","volume":"37","author":"G Klebe","year":"1994","unstructured":"Klebe G, Abraham U, Mietzner T (1994) Molecular similarity indices in a comparative analysis (CoMSIA) of drug molecules to correlate and predict their biological activity. J Med Chem 37:4130\u20134146","journal-title":"J Med Chem"},{"key":"9375_CR29","doi-asserted-by":"crossref","first-page":"2681","DOI":"10.1021\/jm00014a020","volume":"38","author":"AR Ortiz","year":"1995","unstructured":"Ortiz AR, Pisabarro MT, Gago F, Wade RC (1995) Prediction of drug binding affinities by comparative binding energy analysis. J Med Chem 38:2681\u20132691","journal-title":"J Med Chem"},{"key":"9375_CR30","doi-asserted-by":"crossref","first-page":"3033","DOI":"10.1021\/jm000934y","volume":"43","author":"MA Kastenholz","year":"2000","unstructured":"Kastenholz MA, Pastor M, Cruciani G, Haaksma EE, Fox T (2000) GRID\/CPCA: a new computational tool to design selective ligands. J Med Chem 43:3033\u20133044","journal-title":"J Med Chem"},{"key":"9375_CR31","doi-asserted-by":"crossref","first-page":"4153","DOI":"10.1021\/jm020808p","volume":"45","author":"H Gohlke","year":"2002","unstructured":"Gohlke H, Klebe G (2002) DrugScore meets CoMFA: adaptation of fields for molecular comparison (AFMoC) or how to tailor knowledge-based pair-potentials to a particular protein. J Med Chem 45:4153\u20134170","journal-title":"J Med Chem"},{"key":"9375_CR32","doi-asserted-by":"crossref","first-page":"5541","DOI":"10.1021\/jm0497141","volume":"47","author":"JJ Sutherland","year":"2004","unstructured":"Sutherland JJ, O\u2019Brien LA, Weaver DF (2004) A comparison of methods for modeling quantitative structure-activity relationships. J Med Chem 47:5541\u20135554","journal-title":"J Med Chem"},{"key":"9375_CR33","doi-asserted-by":"crossref","first-page":"2243","DOI":"10.1021\/ci8002182","volume":"48","author":"LB Salum","year":"2008","unstructured":"Salum LB, Polikarpov I, Andricopulo AD (2008) Structure-based approach for the study of estrogen receptor binding affinity and subtype selectivity. J Chem Inf Model 48:2243\u20132253","journal-title":"J Chem Inf Model"},{"key":"9375_CR34","doi-asserted-by":"crossref","first-page":"2606","DOI":"10.1021\/ci900316e","volume":"49","author":"NF Valadares","year":"2009","unstructured":"Valadares NF, Salum LB, Polikarpov I, Andricopulo AD, Garratt RC (2009) Role of halogen bonds in thyroid hormone receptor selectivity: pharmacophore-based 3D-QSSR studies. J Chem Inf Model 49:2606\u20132616","journal-title":"J Chem Inf Model"},{"key":"9375_CR35","doi-asserted-by":"crossref","first-page":"2140","DOI":"10.1021\/ci800253u","volume":"48","author":"G Sch\u00fc\u00fcrmann","year":"2008","unstructured":"Sch\u00fc\u00fcrmann G, Ebert RU, Chen J, Wang B, K\u00fchne R (2008) External validation and prediction employing the predictive squared correlation coefficient test set activity mean vs training set activity mean. J Chem Inf Model 48:2140\u20132145","journal-title":"J Chem Inf Model"},{"key":"9375_CR36","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1016\/j.jmb.2004.08.018","volume":"343","author":"S Patel","year":"2004","unstructured":"Patel S, Vuillard L, Cleasby A, Murray CW, Yon J (2004) Apo and inhibitor complex structures of BACE (beta-secretase). J Mol Biol 343:407\u2013416","journal-title":"J Mol Biol"},{"key":"9375_CR37","doi-asserted-by":"crossref","first-page":"4689","DOI":"10.1021\/bi0498252","volume":"43","author":"L Hong","year":"2004","unstructured":"Hong L, Tang J (2004) Flap position of free memapsin 2 (beta-secretase), a model for flap opening in aspartic protease catalysis. Biochemistry 43:4689\u20134695","journal-title":"Biochemistry"},{"key":"9375_CR38","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1021\/jm901408p","volume":"53","author":"Z Zhu","year":"2010","unstructured":"Zhu Z, Sun ZY, Ye Y, Voigt J, Strickland C, Smith EM, Cumming J, Wang L, Wong J, Wang YS, Wyss DF, Chen X, Kuvelkar R, Kennedy ME, Favreau L, Parker E, McKittrick BA, Stamford A, Czarniecki M, Greenlee W, Hunter JC (2010) Discovery of cyclic acylguanidines as highly potent and selective beta-site amyloid cleaving enzyme (BACE) inhibitors: Part I-inhibitor design and validation. J Med Chem 53:951\u2013965","journal-title":"J Med Chem"},{"key":"9375_CR39","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.bmcl.2008.11.027","volume":"19","author":"TG Steele","year":"2009","unstructured":"Steele TG, Hills ID, Nomland AA, de Le\u00f3n P, Allison T, McGaughey G, Colussi D, Tugusheva K, Haugabook SJ, Espeseth AS, Zuck P, Graham SL, Stachel SJ (2009) Identification of a small molecule beta-secretase inhibitor that binds without catalytic aspartate engagement. Bioorg Med Chem Lett 19:17\u201320","journal-title":"Bioorg Med Chem Lett"},{"key":"9375_CR40","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1007\/s10822-009-9278-z","volume":"23","author":"A Xie","year":"2009","unstructured":"Xie A, Odde S, Prasanna S, Doerksen RJ (2009) Imidazole-containing farnesyltransferase inhibitors: 3D quantitative structure-activity relationships and molecular docking. J Comput Aided Mol Des 23:431\u2013448","journal-title":"J Comput Aided Mol Des"},{"key":"9375_CR41","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1021\/ci800390m","volume":"49","author":"RR Mittal","year":"2009","unstructured":"Mittal RR, Harris L, McKinnon RA, Sorich MJ (2009) Partial charge calculation method affects CoMFA QSAR prediction accuracy. J Chem Inf Model 49:704\u2013709","journal-title":"J Chem Inf Model"},{"key":"9375_CR42","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1016\/S1093-3263(01)00123-1","volume":"20","author":"A Golbraikh","year":"2002","unstructured":"Golbraikh A, Tropsha A (2002) Beware of q2!. J Mol Graph Model 20:269\u2013276","journal-title":"J Mol Graph Model"}],"container-title":["Journal of Computer-Aided Molecular Design"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10822-010-9375-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10822-010-9375-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10822-010-9375-z","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,31]],"date-time":"2019-05-31T01:23:03Z","timestamp":1559265783000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10822-010-9375-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,7,27]]},"references-count":42,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2010,10]]}},"alternative-id":["9375"],"URL":"https:\/\/doi.org\/10.1007\/s10822-010-9375-z","relation":{},"ISSN":["0920-654X","1573-4951"],"issn-type":[{"value":"0920-654X","type":"print"},{"value":"1573-4951","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010,7,27]]}}}